Home

Kalt stellen Heilige Radioaktivität achim m aigner leipzig university Ente Kapillaren Schnell

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Module III – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

logistics - Stadt Leipzig
logistics - Stadt Leipzig

Cell-type specific and non-redundant anti-proliferative effects of  shRNA-mediated Galpha12- and Galpha13 knockdown in lung cancer cell lines
Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung cancer cell lines

Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in  vitro and in vivo primarily through the modulation of c
Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of c

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Synthetic circular miR-21 RNA decoys enhance tumor suppressor expression  and impair tumor growth in mice
Synthetic circular miR-21 RNA decoys enhance tumor suppressor expression and impair tumor growth in mice

MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards  Therapy
MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards Therapy

Analysis of cellular and molecular antitumor effects upon inhibition of  SATB1 in glioblastoma cells
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis  in prostate carcinoma and melanoma
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma

A big thank you to our reviewers in the past year!
A big thank you to our reviewers in the past year!

Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI)  Strongly Improves Efficacy of siRNA-Mediated Gene Kn
Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Kn

Achim Aigner: H-index & Awards - Academic Profile | Research.com
Achim Aigner: H-index & Awards - Academic Profile | Research.com

Inhibition of HER Receptors Reveals Distinct Mechanisms of Compensatory  Upregulation of Other HER Family Members: Basis for Acqu
Inhibition of HER Receptors Reveals Distinct Mechanisms of Compensatory Upregulation of Other HER Family Members: Basis for Acqu

Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and  Drug‐likeness: Biological and Physicochemical Evaluation of Class I  Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 -  ChemMedChem - Wiley Online Library
Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 - ChemMedChem - Wiley Online Library

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile